RNS Number : 0648C
MAC Alpha Limited
18 February 2022
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA OR ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO.

 

LEI number: 254900LOBYWJWYSAB947

18 February 2022

 

MAC Alpha Limited

(the "Company")

Interim Report for the period ended 31 December 2021

The Company announces its interim results for the period ended 31 December 2021.

 

The Interim Report is also available on the 'Shareholder Documents' page of the Company's website at www.mac-alpha.com.

 

Enquiries:

 

Company Secretary

Antoinette Vanderpuije -  +44(0)207 004 2700

 

 MAC ALPHA LIMITED

Unaudited Interim Condensed Consolidated Financial Statements for the period from incorporation on 11 October 2021 to 31 December 2021

 

MANAGEMENT REPORT

 

I present to shareholders the unaudited interim condensed consolidated financial statements of MAC Alpha Limited (the "Company") for the period from incorporation on 11 October 2021 to 31 December 2021 (the "Condensed Consolidated Interim Financial Statements"), consolidating the results of MAC Alpha Limited and its subsidiary MAC Alpha (BVI) Limited (collectively, the "Group" or "MAC").

 

Strategy

 

The Company was incorporated on 11 October 2021 and subsequently listed on the Main Market of the London Stock Exchange on 24 December 2021. The Company has been formed for the purpose of effecting a merger, share exchange, asset acquisition, share or debt purchase, reorganisation or similar business combination with one or more businesses. The Company's objective is to generate attractive long term returns for shareholders and to enhance value by supporting sustainable growth, acquisitions and performance improvements within the acquired companies. 

 

While a broad range of sectors will be considered by the Directors, those which they believe will provide the greatest opportunity and which the Company will initially focus on include:

·      Automotive & Transport

·      Business-to-Business Services

·      Clean Technology

·      Consumer & Luxury Goods

·      Financial Services, Banking & Fin Tech

·      Insurance, Reinsurance & InsurTech, & Other Vertical Marketplaces

·      Media & Technology

·      Healthcare & Diagnostics

The Directors may consider other sectors if they believe such sectors present a suitable opportunity for the Company.

 

The Company will seek to identify situations where a combination of management expertise, improving operating performance, freeing up cashflow for investment and implementation of a focused buy and build strategy can unlock growth in their core markets and often into new territories and adjacent sectors.

 

Results

The Group's loss after taxation for the period to 31 December 2021 was £122,400. The Group held a cash balance at the period end of £700,000 and had payables of £354,795 as at the balance sheet date.

 

Directors

The Directors of the Company have served as directors for the period from incorporation until the date of this report. The Directors are:

 

James Corsellis (Chairman); and 

Mark Brangstrup Watts.

 

Dividend Policy

The Company has not yet acquired a trading business and it is therefore inappropriate to make a forecast of the likelihood of any future dividends. The Directors intend to determine the Company's dividend policy following completion of an acquisition and, in any event, will only commence the payment of dividends when it becomes commercially prudent to do so.

 

Corporate Governance

As a company with a Standard Listing, the Company is not required to comply with the provisions of the UK Corporate Governance Code and given the size and nature of the Group the Directors have decided not to adopt the UK Corporate Governance Code. Nevertheless, the Board is committed to maintaining high standards of corporate governance and will consider whether to voluntarily adopt and comply with the UK Corporate Governance Code as part of any acquisition, taking into account the Company's size and status at that time.

The Company currently complies with the following principles of the UK Corporate Governance Code:

·      The Company is led by an effective and entrepreneurial Board, whose role is to promote the long term sustainable success of the Company, generating value for shareholders and contributing to wider society.

·      The Board ensures that it has the policies, processes, information, time and resources it needs in order to function effectively and efficiently.

·      The Board ensures that the necessary resources are in place for the company to meet its objectives and measure performance against them.

 

Given the size and nature of the Company, the Board has not established any committees and intends to make decisions as a whole. If the need should arise in the future, for example following any acquisition, the Board may set up committees and may decide to comply with the UK Corporate Governance Code.

 

Risks

The Directors have carried out a robust assessment of the principal risks facing the Group including those that would threaten its business model, future performance, solvency, or liquidity. There have been no significant changes to the principal risks described in the Company's Prospectus published on 24 December 2021. Details of the risks faced by the Group are set out on pages 11-22 of the Prospectus which can be found on the Company's website www.mac-alpha.com. 

 

Outlook

We are active in pursuing and evaluating opportunities with advisers and potential management partners and believe the structure of the Company positions it well to capitalise on these opportunities in the current market environment.

 

RESPONSIBILITY STATEMENT

 

Each of the Directors confirms that, to the best of their knowledge:

(a) these Condensed Consolidated Interim Financial Statements, which have been prepared in accordance with IAS 34 "Interim Financial Reporting" as adopted by the European Union, give a true and fair view of the assets, liabilities, financial position and profit or loss of MAC; and

(b) these Condensed Consolidated Interim Financial Statements comply with the requirements of DTR 4.2.

 

Neither the Company nor the Directors accept any liability to any person in relation to the Condensed Consolidated Interim Financial Statements except to the extent that such liability could arise under applicable law.

 

Details on the Company's Board of Directors can be found on the Company website at www.mac-alpha.com.

 

 

James Corsellis
Chairman
17 February 2022

 

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

 

 

 

Period from incorporation to

 

 

31 December

 

 

2021

 

Note

Unaudited

 

 

£

 

 

 

Administrative expenses

6

(122,400)

Total operating loss

 

(122,400)

 

 

 

Income tax

 

-

Loss for the period

 

(122,400)

Total other comprehensive income

 

-

Total comprehensive loss for the period

 

 

(122,400)

 

 

 

Loss per ordinary share

 

 

Basic and Diluted (£)

7

(0.17)

 

The Group's activities derive from continuing operations.

 

The Notes on pages 9 to 18 form an integral part of these Condensed Consolidated Interim Financial Statements.

 

CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION

 

 

 

As at

31 December

2021

 

Note

Unaudited

 

 

£

Assets

 

 

Current assets

 

 

Cash and cash equivalents

10

700,000

Other receivables

9

23,912

Total current assets

 

723,912

 

 

 

Total assets

 

 

 

 

Equity and liabilities

 

 

Equity

 

 

Ordinary Shares

12

319,000

Sponsor share

12

1

Warrants reserve

12

105,000

Share-based payment reserve

14

67,516

Accumulated losses

 

(122,400)

Total equity

 

369,117

 

 

 

Current liabilities

 

 

Trade and other payables

11

354,795

Total liabilities

 

354,795

 

 

 

Total equity and liabilities

 

723,912

 

The Notes on pages 9 to 18 form an integral part of these Condensed Consolidated Interim Financial Statements.

 

The Condensed Consolidated Interim Financial Statements were approved by the Board of Directors on 17 February 2022 and were signed on its behalf by:

 

 

James Corsellis

Mark Brangstrup Watts

Chairman

Director

 

 

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

 

 

 

 Notes

Ordinary shares

Sponsor Share

Share based payment reserve

Warrant reserve

Accumulated losses

Total equity

 

 

£

£

£

 

£

£

Balance at incorporation

 

-

-

-

-

-

-

Issuance of 1 ordinary share

12

1

-

-

-

-

1

Redesignation of 1 ordinary share

12

(1)

1

-

-

-

-

Issuance of 700,000 ordinary shares and matching warrants

12

595,000

-

-

105,000

-

 700,000

Share issue costs

12

(276,000)

-

-

-

-

(276,000)

Total comprehensive loss for the period

 

-

-

-

-

(122,400)

(122,400)

Issuance of 2,000 A ordinary shares in MAC Alpha

(BVI) Limited

14

-

-

15,000

-

-

15,000

Share-based payment charge

 14

-

-

52,516

-

-

52,516

Balance as at 31 December 2021

 

319,000

1

67,516

105,000

(122,400)

369,117

 

 

The Notes on pages 9 to 18 form an integral part of these Condensed Consolidated Interim Financial Statements.

 

 

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

 

 

Period from incorporation to 

31 December

2021

 

Note

Unaudited

 

 

£

 

 

 

Operating activities

 

 

Loss for the period

 

(122,400)

 

 

 

Adjustments to reconcile total operating loss to net cash flows:

 

 

Add back share based payment expense

14

52,516

Working capital adjustments:

 

 

   Increase in trade and other receivables and prepayments

 

(23,912)

   Increase in trade and other payables

 

354,795

Net cash flows used in operating activities

 

260,999

 

 

 

Financing activities

 

 

Proceeds from issue of ordinary share capital, matching warrants and 1 sponsor share

 12

700,001

Proceeds from issue of A ordinary shares

14

15,000

Cost of share issuance 

12

(276,000)

Net cash flows from financing activities

 

439,001

 

 

 

Net increase in cash and cash equivalents

 

700,000

Cash and cash equivalents at the beginning of the period

 

-

Cash and cash equivalents at the end of the period

10

700,000

 

The Notes on pages 9 to 18 form an integral part of these Consolidated Interim Financial Statements.

 

NOTES TO THE CONSOLIDATED INTERIM FINANCIAL STATEMENTS

 

1.    GENERAL INFORMATION

 

MAC Alpha Limited was incorporated on 11 October 2021 in the British Virgin Islands ("BVI") as a BVI business company (registered number 2078235) under the BVI Business Company Act, 2004. The Company was listed on the Main Market of the London Stock Exchange on 24 December 2021 and has its registered address at Commerce House, Wickhams Cay 1, P.O. Box 3140, Road Town, Tortola, British Virgin Islands VG1110. The Company has been formed for the purpose of effecting a merger, share exchange, asset acquisition, share or debt purchase, reorganisation or similar business combination with one or more businesses. The Company has one subsidiary, MAC Alpha (BVI) Limited (together with the Company the "Group").

 

2.    ACCOUNTING POLICIES

 

(a)    Basis of preparation

The Condensed Consolidated Interim Financial Statements have been prepared in accordance with the IAS 34 interim financial reporting and are presented on a condensed basis. The interim report does not include all of the notes of the type normally included in an annual financial report. There have been no annual financial statements prepared to date as this is the first interim period, however this report should be read in conjunction with any public announcements made by the Company during the interim period.

 

(b)   Going concern

The Condensed Consolidated Interim Financial Statements relating to the Group have been prepared on a going concern basis, which assumes that the Group will continue to be able to meet its liabilities as they fall due within the next twelve months from the date of approval.

 

As part of the Company's admission onto the Main Market of the London Stock Exchange, the Directors have reviewed the working capital model for the Group in detail and are satisfied that the Company will have sufficient cash to meet its ongoing operating costs, at least for the next twelve months. Subject to the structure of an acquisition, the Company will likely need to raise additional funds for an acquisition in the form of equity and/or debt. Significant risks relating to the activities of the Company were set out in the Company's prospectus relating to its admission to the Main Market of the London Stock Exchange which can be found on the Company's website.

 

(c)    Basis of consolidation

Subsidiaries are entities controlled by the Company. Control exists when the Company is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. The financial information of subsidiaries is fully consolidated in the consolidated interim financial statements from the date that control commences until the date that control ceases. Intragroup balances, and any gains and losses or income and expenses arising from intragroup transactions, are eliminated in preparing the consolidated interim financial statements.

 

(d)   Cash and cash equivalents

The Cash and cash equivalents comprise cash balances at banks.

 

(e)   Stated capital

Ordinary shares and sponsor shares are classified as equity. Incremental costs directly attributable to the issue of new shares are shown in the associated stated capital as a deduction from the proceeds.

 

(f)    Share based payments

The A ordinary shares in MAC Alpha (BVI) Limited (the "Incentive Shares"), represent equity-settled share-based payment arrangements under which the Company receives services as a consideration for the additional rights attached to these equity shares, over and above their nominal price.

 

Equity-settled share-based payments to Directors and others providing similar services are measured at the fair value of the equity instruments at the grant date. Fair value is determined using an appropriate valuation technique, further details of which are given in note 14. The fair value is expensed, with a corresponding increase in equity, on a straight line basis from the grant date to the expected exercise date. Where the equity instruments granted are considered to vest immediately, the services are deemed to have been received in full, with a corresponding expense and increase in equity recognised at grant date.

 

(g)   Corporation tax

There is no corporate, income or other tax of the British Virgin Islands imposed by withholding or otherwise on BVI companies. The Company will therefore not have any tax liabilities or deferred tax in the BVI. The Company is exempt from all provisions of the Income Tax Act of the British Virgin Islands.

 

(h)   Loss per ordinary share

The Group presents basic earnings per ordinary share ("EPS") data for its ordinary shares. Basic EPS is calculated by dividing the profit or loss attributable to ordinary shareholders of the Company by the weighted average number of ordinary shares outstanding during the period. Diluted EPS is calculated by adjusting the weighted average number of ordinary shares outstanding to assume conversion of all dilutive potential ordinary shares.

 

(i)    Financial instruments

A financial instrument is any contract that gives rise to a financial asset of one entity and a financial liability or equity instrument of another entity. The Group initially recognises financial assets and financial liabilities at fair value. Financial assets and liabilities are subsequently remeasured at amortised cost using the effective interest rate. The Group derecognises the financial assets when the right to receive cash flows have expired, and derecognises financial liabilities when they have transferred all risks and rewards of ownership.

 

(j)     New standards and amendments to International Financial Reporting Standards

Standards, amendments and interpretations effective and adopted by the Group

IFRSs applicable to the Condensed Consolidated Interim Financial Statements of the Group for the period from incorporation 11 October 2021 to 31 December 2021 have been applied consistently.

 

Standards issued but not yet effective

The following standards are issued but not yet effective. The Group intends to adopt these standards, if applicable, when they become effective. It is not currently expected that these standards will have a material impact on the Group.

Standard

Effective date

Onerous Contracts - Cost of Fulfilling a Contract (Amendments to IAS 37)

1 January 2022

Property, Plant and Equipment: Proceeds before Intended Use (Amendments to IAS 16)

1 January 2022

Annual Improvements to IFRS Standards 2018-2020 (Amendments to IFRS 1, IFRS 9, IFRS 16 and IAS 41)

1 January 2022

Amendments to IFRS 3: References to Conceptual Framework

1 January 2022

Amendments to IAS 1 Presentation of Financial Statements: Classification of Liabilities as Current or Non-current

1 January 2023

Disclosure of accounting policies (Amendments to IAS 1)

1 January 2023

Definition of accounting estimates (Amendments to IAS 8)

1 January 2023

IFRS 17 Insurance contracts

1 January 2023

Amendments to IAS 12 Income Taxes: Deferred tax related to assets and liabilities arising from a similar transaction

1 January 2023

 

3.    CRITICAL ACCOUNTING JUDGEMENTS AND ESTIMATES

The preparation of the Group's Condensed Consolidated Interim Financial Statements under IFRS requires the Directors to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities. Estimates and judgements are continually evaluated and are based on historical experience and other factors including expectations of future events that are believed to be reasonable under the circumstances. Actual results may differ from these estimates.

Critical accounting judgements

Classification of warrants

As part of the Company's initial fundraising on IPO, the Company issued ordinary shares to a number of investors. For every ordinary share subscribed for, each investor was also granted a warrant ("Warrant") to acquire a further ordinary share at an exercise price of £1.00 per share. The Warrants are exercisable at any time until five years after the IPO date, being 24 December 2021.

Warrants can only be classified as equity if they will be settled only by the issuer exchanging a fixed amount of cash or another financial asset for a fixed number of its own equity instruments. The warrant instrument contains an exercise price adjustment ("Exercise Price Adjustment"), whereby if the ordinary shares are issued at less than £1 before or as part of an acquisition then the exercise price equals the discounted issue price, as a result the fixed-for-fixed requirement is breached. However, it is the opinion of the Directors that whilst the Exercise Price Adjustment exists, the likelihood of this being used is remote, and therefore it is most appropriate for the Warrants to be classified as equity.

 

Key sources of estimation uncertainty

Valuation of incentive shares

There are significant estimates and assumptions used in the valuation of the A ordinary Shares in MAC Alpha (BVI) Limited the ("Incentive Shares"). Management has considered at the grant date, the probability of a successful first acquisition by the Group and the potential range of value for the Incentive Shares, based on the circumstances on the grant date. The fair value of the Incentive Shares and related share-based payment expense was calculated using a Monte Carlo valuation model. A summary of the terms is set out in note 14.

Valuation of warrants

The Warrants were valued using the Black Scholes option pricing methodology which considered the exercise price, expected volatility, risk free rate, expected dividends and expected term of the Warrants.

 

4.    SEGMENT INFORMATION

The Board of Directors is the Group's chief operating decision-maker. As the Group has not yet commenced trading, the Board of Directors considers the Group as a whole for the purposes of assessing performance and allocating resources, and therefore the Group has one reportable operating segment.

5.    EMPLOYEES AND DIRECTORS

The Group does not have any employees. During the period ended 31 December 2021, the Company had two directors: James Corsellis and Mark Brangstrup Watts, neither director received remuneration under the terms of their director service agreements.

6.    ADMINISTRATIVE EXPENSES

 

For the period

from incorporation to 31 December 2021

 

£

Group expenses by nature

 

Professional support

18,521

Non-recurring project, professional and due diligence costs

50,610

Share based payment expense

52,516

Other expenses

753

 

122,400

 

7.    LOSS PER ORDINARY SHARE

Basic EPS is calculated by dividing the profit/ loss attributable to equity holders of the company by the weighted average number of ordinary shares in issue during the period. Diluted EPS is calculated by adjusting the weighted average number of ordinary shares outstanding to assume conversion of all dilutive potential ordinary shares. The weighted average number of shares has not been adjusted in calculating diluted EPS as there are no instruments which have a current dilutive effect. The Company has issued 700,000 warrants, each of which is convertible into one ordinary share. The group made a loss in the current period, which would result in the warrants being anti-dilutive. Therefore, the warrants have not been included in the calculation of diluted earnings per share.

The Company has 700,000 ordinary shares and 1 sponsor share in issue as 31 December 2021. The sponsor share has no right to receive distributions and so has been ignored for the purposes of IAS 33.

Refer to note 12 (equity and reserves) and note 14 (share based payments) for instruments that could potentially dilute basic EPS in the future.

 

For the period from incorporation to 31 December 2021

Loss attributable to owners of the parent (£)

(122,400)

Weighted average number of ordinary shares in issue

700,000

Basic and diluted loss per ordinary share (£)

(0.17)

 

8.    INVESTMENTS

Principal subsidiary undertakings of the Group

The Company owns directly the whole of the issued ordinary share capital of its subsidiary undertaking. Details of the Company's subsidiary are presented below:

 

 

 

Subsidiary

Nature of business

Country of incorporation

Proportion of ordinary shares held by parent

Proportion of ordinary shares held by the Group

 

 

 

 

 

MAC Alpha (BVI) Limited

 Incentive vehicle

BVI

100%

100%

 

The registered office of MAC Alpha (BVI) Limited Commerce House, Wickhams Cay 1, P.O. Box 3140, Road Town, Tortola, British Virgin Islands VG1110.

 

The share capital of MAC Alpha (BVI) Limited consists of both ordinary shares and A ordinary shares. The A ordinary shares are held by Marwyn Long Term Incentive LP (''MLTI'') and are non-voting. Further detail on the Incentive Shares is given in note 14.

 

9.    OTHER RECEIVABLES

 

As at

31 December 2021

 

£

Amounts receivable in one year:

 

Prepayments

8,911

Due from a related party

15,001

 

23,912

There is no material difference between the book value and the fair value of the receivables.

 

10.  CASH AND CASH EQUIVALENTS

 

As at

31 December 2021

 

£

Cash and cash equivalents

 

Cash at bank

700,000

 

700,000

 

Credit risk is managed on a group basis. Credit risk arises from cash and cash equivalents and deposits with banks and financial institutions. For banks and financial institutions, only independently rated parties with a minimum short-term credit rating of P-1, as issued by Moody's, are accepted.

 

11.  TRADE AND OTHER PAYABLES

 

As at

31 December 2021

 

£

Amounts falling due within one year:

 

Trade payables

161,080

Due to a related party

173,694

Accruals

20,021

 

354,795

 

There is no material difference between the book value and the fair value of the trade and other payables.

 

All trade payables are non-interest bearing and are usually paid within 30 days.

 

12.  EQUITY AND RESERVES

 

 

Authorised

 

Unlimited ordinary shares of no par value

 

Unlimited class A shares of no par value

 

Unlimited class B shares of no par value

 

100 sponsor shares of no par value

 

 

Stated capital

 

As at 31 December 2021

Issued

£

700,000 ordinary shares of no par value

319,000

1 sponsor share of no par value

1

 

 

On incorporation, the Company issued 1 ordinary share of no par value to the Parent. On 28 October 2021, it was resolved that updated memorandum and articles ("Updated M&A") be adopted by the Company and with effect from the time the Updated M&A be registered with the Registrar of Corporate Affairs in the British Virgin Islands, the 1 ordinary share which was in issue by the Company be redesignated as 1 sponsor share of no par value (the "Sponsor Share").

 

On 24 December 2021, the Company issued 700,000 ordinary shares and matching Warrants at a price of £1 for one ordinary share and matching Warrant.  Under the terms of the warrant instrument, warrant holders are able to acquire one ordinary share per warrant at a price of £1 per ordinary share.  Warrants are accounted for as equity instruments under IAS 32 and are measured at fair value at grant date, the combined market value of one ordinary share and one warrant was considered to be £1, in line with the market price paid by third party investors. A Black Scholes option pricing methodology was used to determine the fair value of the Warrants, which considered the exercise price, expected volatility, risk free rate, expected dividends and expected term. Warrants have been assigned a fair value of 15p per Warrant and therefore each ordinary share has been valued at 85p per share.

 

Costs of £276,000 directly attributable to the equity raise have been taken against stated capital during the period.

 

Holders of ordinary shares are entitled to receive notice and attend and vote at any meeting of members and have the right to a share in any distribution paid by the Company and a right to a share in the distribution of the surplus assets of the Company on a winding up.

 

The Sponsor Share confers upon the holder no right to receive notice and attend and vote at any meeting of members, no right to any distribution paid by the Company and no right to a share in the distribution of the surplus assets of the Company on a summary winding up. Provided the holder of the Sponsor Share holds directly or indirectly 5 per cent. or more of the issued and outstanding shares of the Company (of whatever class other than any Sponsor Shares), they have the right to appoint one director to the Board.

 

The Sponsor Share confers upon the holder no right to receive notice and attend and no right to vote at any meeting of members, no right to any distribution paid by the Company and no right to a share in the distribution of the surplus assets of the Company on a summary winding up.

 

Provided the holder of the Sponsor Share holds directly or indirectly 5 per cent. or more of the issued and outstanding shares of the Company (of whatever class other than any Sponsor Shares), the holder of the Sponsor Share has the right to appoint one director to the Board.

 

Provided the holder of the Sponsor Share holds directly or indirectly 5 per cent. or more of the issued and outstanding shares of the Company (of whatever class other than any Sponsor Shares) or is a holder of incentive shares:

·      the Company must receive the prior consent of the holder of the Sponsor Share in order to:

issue any further Sponsor Shares;

issue any class of shares on a non pre-emptive basis where the Company would be required to issue such share pre-emptively if it were incorporated under the UK Companies Act 2006 and acting in accordance with the Pre-Emption Group's Statement of Principles; or

amend, alter or repeal any existing, or introduce any new share-based compensation or incentive scheme in respect of the Group; and

take any action that would not be permitted (or would only be permitted after an affirmative shareholder vote) if the Company were admitted to the Premium Segment of the Official List.

·      the holder of the Sponsor Share has the right to require that: (i) any purchase or redemption by the Company of its shares; or (ii) the Company's ability to amend the Memorandum and Articles, be subject to a special resolution of members.

 

13.  FINANCIAL INSTRUMENTS AND ASSOCIATED RISKS

The Group has the following categories of financial instruments at the period end:

 

As at

31 December 2021

 

£

Financial assets measured at amortised cost

 

Cash and cash equivalents

700,000

Other receivables

15,001

 

715,001

 

 

Financial liabilities measured at amortised cost

 

Trade and other payables

354,795

 

354,795

The fair value and book value of the financial assets and liabilities are materially equivalent.

 

The Group's risk management policies are established to identify and analyse the risks faced by the Group, to set appropriate risk limits and controls, and to monitor risks and adherence limits. Risk management policies and systems are reviewed regularly to reflect changes in market conditions and the Group's activities.

Treasury activities are managed on a Group basis under policies and procedures approved and monitored by the Board. These are designed to reduce the financial risks faced by the Group which primarily relate to movements in interest rates.

As the Group's assets are predominantly cash and cash equivalents, market risk and liquidity risk are not currently considered to be material risks to the Group.

14.  SHARE-BASED PAYMENTS

Management Long Term Incentive Arrangements

The Group has put in place a Long-Term Incentive Plan ("LTIP"), to ensure alignment between Shareholders, and those responsible for delivering the Company's strategy and attract and retain the best executive management talent.

 

The LTIP will only reward the participants if shareholder value is created. This ensures alignment of the interests of management directly with those of Shareholders. As at the balance sheet date, an executive management team is not yet in place and as such Marwyn Long Term Incentive LP ("MLTI") is the only participant in the LTIP. Once an executive management team is appointed, they will participate in the LTIP and this will be dilutive to MLTI. Under the LTIP, A ordinary shares ("Incentive Shares") are issued by the Subsidiary.

 

As at the statement of financial position date, MLTI had subscribed for redeemable A ordinary shares of £0.01 each in the Subsidiary entitling it to 100 per cent.  of the incentive value.

 

Preferred Return

The incentive arrangements are subject to the Company's shareholders achieving a preferred return of at least 7.5 per cent.  per annum on a compounded basis on the capital they have invested from time to time (with dividends and returns of capital being treated as a reduction in the amount invested at the relevant time) (the "Preferred Return").

 

Incentive Value

Subject to a number of provisions detailed below, if the Preferred Return and at least one of the vesting conditions have been met, the holders of the Incentive Shares can give notice to redeem their Incentive Shares for ordinary shares in the Company ("Ordinary Shares") for an aggregate value equivalent to 20 percent of the "Growth", where Growth means the excess of the total equity value of the Company and other shareholder returns over and above its aggregate paid up share capital (20 per cent.  of the Growth being the "Incentive Value").

 

Grant date

The grant date of the Incentive Shares will be the date that such shares are issued.

 

Redemption / Exercise

Unless otherwise determined and subject to the redemption conditions having been met, the Company and the holders of the Incentive Shares have the right to exchange each Incentive Share for Ordinary Shares, which will be dilutive to the interests of the holders of Ordinary Shares. However, if the Company has sufficient cash resources and the Company so determines, the Incentive Shares may instead be redeemed for cash. It is currently expected that in the ordinary course Incentive Shares will be exchanged for Ordinary Shares. However, the Company retains the right but not the obligation to redeem the Incentive Shares for cash instead. Circumstances where the Company may exercise this right include, but are not limited to, where the Company is not authorised to issue additional Ordinary Shares or on the winding-up or takeover of the Company.

Any holder of Incentive Shares who exercises their Incentive Shares prior to other holders is entitled to their proportion of the Incentive Value to the date that they exercise but no more. Their proportion is determined by the number of Incentive Shares they hold relative to the total number of issued shares of the same class.

 

Vesting Conditions and Vesting Period

The Incentive Shares are subject to certain vesting conditions, at least one of which must be (and continue to be) satisfied in order for a holder of Incentive Shares to exercise its redemption right.

The vesting conditions are as follows:

i.              it is later than the third anniversary of the initial acquisition;

ii.             a sale of all or substantially all of the revenue or net assets of the business of the Subsidiary in combination with the distribution of the net proceeds of that sale to the Company and then to its shareholders;

iii.            a sale of all of the issued ordinary shares of the Subsidiary or a merger of the Subsidiary in combination with the distribution of the net proceeds of that sale or merger to the Company's shareholders;

iv.            whereby corporate action or otherwise, the Company effects an in-specie distribution of all or substantially all of the assets of the Group to the Company's shareholders;

v.             aggregate cash dividends and cash capital returns to the Company's Shareholders are greater than or equal to aggregate subscription proceeds received by the Company;

vi.            a winding-up of the Company;

vii.           a winding-up of the Subsidiary; or

viii.          a sale, merger or change of control of the Company.

 

If any of the vesting conditions described in paragraphs (ii) to (viii) above are satisfied before the third anniversary of the initial acquisition, the A Shares will be treated as having vested in full.

 

Holding of Incentive Shares

MLTI holds Incentive Shares entitling it in aggregate to 100 per cent. of the Incentive Value. Any future management partners or senior executive management team members receiving Incentive Shares will be dilutive to the interests of existing holders of Incentive Shares, however the share of the Growth of the Incentive Shares in aggregate will not increase.

 

The following Incentive Shares were issued on 25 November 2021.

 

Nominal Price

Issue price per A ordinary share    £

Number of A ordinary shares

Unrestricted market value at grant date £

IFRS 2 Fair value       £

Marwyn Long Term Incentive LP

£0.01

7.50

2,000

15,000

67,516

 

Valuation of Incentive Shares

A valuation of the incentive shares has been prepared by Deloitte LLP dated 25 November 2021 to determine the fair value of the Incentive Shares in accordance with IFRS 2 at grant date.

 

There are significant estimates and assumptions used in the valuation of the Incentive Shares. Management has considered at the grant date, the probability of a successful first acquisition by the Company and the potential range of value for the Incentive Shares, based on the circumstances on the grant date.

 

The fair value of the Incentive Shares granted under the scheme was calculated using a Monte Carlo model. The fair value uses an ungeared volatility of 25 per cent. and an expected term of seven years. The Incentive Shares are subject to the Preferred Return being achieved, which is a market performance condition, and as such has been taken into consideration in determining their fair value. A risk-free rate of 0.7 per cent. has been applied. The model incorporates a range of probabilities for the likelihood of an acquisition being made of a given size.

 

Expense related to Incentive Shares

An expense of £52,516 has been recognised in the Statement of Comprehensive Income for the period ended 31 December 2021 in respect of the Incentive Shares issued to MLTI which is the difference between the IFRS 2 valuation at grant date of £67,516 and the amount payable by MLTI for 2,000 A ordinary shares of £15,000. There are no service conditions attached to the MLTI shares, and hence the expense of £52,516 has been recognised in the consolidated statement of comprehensive income for the period. The fair value at grant date has been taken to the share-based payment reserve in the statement of changes in equity.

 

15.  RELATED PARTIES

James Corsellis and Mark Brangstrup Watts are directors of the Company and Antoinette Vanderpuije is the Company Secretary of the Company. James Corsellis and Mark Brangstrup Watts are managing partners of Marwyn Investment Management LLP ("MIMLLP"), and Antoinette Vanderpuije is a partner of MIMLLP, MIMLLP is the manager of the Marwyn Fund, the Marwyn Fund holds 90% of the Company's issued ordinary shares.   

Marwyn Value Investor II LP is an entity within the Marwyn Fund. Marwyn Value Investor II LP has incurred costs of £23,382 in respect of the incorporation and proposed listing of the Company, of which £23,382 is outstanding at period end.

 

James Corsellis and Mark Brangstrup Watts are managing partners of Marwyn Capital LLP ("MCLLP"), and Antoinette Vanderpuije is a partner of MCLLP. MCLLP has entered into an engagement letter with the Company for the provision of corporate finance, company secretarial, administration and accounting services. As part of this engagement a fee of £150,000 has been charged in relation to the establishment of the Company and the subsequent listing, of which £150,000 is outstanding at period end.

 

MCLLP has incurred costs of £312 in respect of the incorporation and listing of the Company, of which £312 was outstanding at the period end.

 

16.  COMMITMENTS AND CONTINGENT LIABILITIES

There were no commitments or contingent liabilities outstanding at 31 December 2021 that requires disclosure or adjustment in these financial statements.

 

17.  POST BALANCE SHEET EVENTS

There have been no material post balance sheet events that would require disclosure or adjustment to these financial statements. 

 

ADVISORS

 

Company Secretary

BVI legal advisers to the Company

Antoinette Vanderpuije

Conyers Dill & Pearman

11 Buckingham Street

Commerce House

London

Wickhams Cay 1

WC2N 6DF

Road Town

Email: Companysecretary@mac-alpha.com

Tortola

 

British Virgin Islands

 

 VG1110

 

 

Registered Agent and Assistant Company Secretary

Depository

Conyers Corporate Services (BVI) Limited

Link Market Services Trustees Limited

Commerce House

10th Floor

Wickhams Cay 1

Central Square

Road Town

29 Wellington Street

VG1110

Leeds

Tortola

LS1 4DL

British Virgin Islands

 

 

 

English legal advisers to the Company

Registrar

Travers Smith LLP

Link Market Services (Guernsey) Limited

10 Snow Hill

Mont Crevelt House

London

Bulwer Avenue

EC1A 2AL

St Sampson

 

Guernsey

 

GY2 4LH

 

 

Registered office

Independent auditor

Commerce House

Baker Tilly Channel Islands

Wickhams Cay 1

1st Floor Kensington Chambers

Road Town

46/50 Kensington Place

VG1110

St Helier

Tortola

Jersey

British Virgin Islands

JE04 0ZE

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR SFDEEWEESESE